Collectively, these reports, together with our findings, suggest that a PKCδ-targeted approach to breast cancer stem cell populations, which exploits a synthetic lethal interaction with aberrant Ras signaling, may be particularly effective. Here, PRKCD is linked to breast carcinoma.